Thymidylate Synthase Gene Polymorphism Predicts Toxicity in Colorectal Cancer Patients Receiving 5-Fluorouracil-based Chemotherapy
Thierry Lecomte(Université Paris Cité), Pierre Laurent‐Puig(Inserm), David‐Alexandre Trégouët(Université de Bordeaux), Franck Zinzindohoué(Assistance Publique – Hôpitaux de Paris), Bruno Landi, Jean‐Marc Ferraz(Assistance Publique – Hôpitaux de Paris), Paul‐Henri Cugnenc(Assistance Publique – Hôpitaux de Paris), Raymond Jian(Research Institute of Animal Husbandry), Philippe Beaune(Inserm), Anne Berger(Délégation Paris 5), Marie‐Anne Loriot(Unknown)
Cited by 241
Related Papers
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
|Immunity|2013|4.7k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k